130 related articles for article (PubMed ID: 8824357)
1. Phase II trial of edatrexate in patients with metastatic colorectal cancer.
Clamon GH; Riggs CE; Dreicer R; Hohl RJ
Invest New Drugs; 1996; 13(4):359-61. PubMed ID: 8824357
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
Pazdur R; Moore DF; Bready B; Giannone L; Maldonado A; Lin YG; Fueger RH; Winn RJ; Levin B
Ann Oncol; 1994 Sep; 5(7):646-8. PubMed ID: 7527654
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy.
Edelman MJ; Gandara DR; Perez EA; Lau D; Lauder I; Turrell C; Uhrich M; Meyers F
Invest New Drugs; 1998; 16(1):69-75. PubMed ID: 9740546
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study.
Broun ER; Iseminger KA; Bookman M
Am J Clin Oncol; 1995 Apr; 18(2):164-6. PubMed ID: 7900709
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Moore DF; Pazdur R; Abbruzzese JL; Ajani JA; Dubovsky DW; Wade JL; Belt RJ; Mangold C; Bready B; Winn RJ
Ann Oncol; 1994 Mar; 5(3):286-7. PubMed ID: 8186177
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
Schornagel JH; van der Vegt S; Verweij J; de Graeff A; Dullemond-Westland A; van Deijk WA; ten Bokkel Huinink WW
Ann Oncol; 1992 Jul; 3(7):549-52. PubMed ID: 1498076
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
Kuebler JP; Benedetti J; Schuller DE; Ensley J; Grunberg SM; Muirhead MJ; Richert-Boe KE; Marshall ME
Invest New Drugs; 1994; 12(4):341-4. PubMed ID: 7775138
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
Broun ER; Iseminger KA; Rose PG; Lentz SL; Malfetano JH; Lincoln S; Mannel R
Am J Clin Oncol; 1997 Feb; 20(1):78-80. PubMed ID: 9020294
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).
Meyers FJ; Lew D; Lara PN; Williamson S; Marshall E; Balcerzak SP; Rivkin SE; Samlowski W; Crawford ED
Invest New Drugs; 1998-1999; 16(4):347-51. PubMed ID: 10426670
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of edatrexate in advanced breast and other cancers.
Kuriakose P; Gandara DR; Perez EA
Cancer Invest; 2002; 20(4):473-9. PubMed ID: 12094542
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
Krug LM; Ng KK; Kris MG; Miller VA; Tong W; Heelan RT; Leon L; Leung D; Kelly J; Grant SC; Sirotnak FM
Clin Cancer Res; 2000 Sep; 6(9):3493-8. PubMed ID: 10999734
[TBL] [Abstract][Full Text] [Related]
13. Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.
Casper ES; Christman KL; Schwartz GK; Johnson B; Brennan MF; Bertino JR
Cancer; 1993 Aug; 72(3):766-70. PubMed ID: 8392904
[TBL] [Abstract][Full Text] [Related]
14. Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
Kindler HL; Belani CP; Herndon JE; Vogelzang NJ; Suzuki Y; Green MR
Cancer; 1999 Nov; 86(10):1985-91. PubMed ID: 10570422
[TBL] [Abstract][Full Text] [Related]
15. Edatrexate studies in non-small cell lung cancer.
Gralla RJ
Lung Cancer; 1995 Apr; 12 Suppl 1():S187-91. PubMed ID: 7551928
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Casper ES; Schwartz GK; Johnson B; Kelsen DP
Invest New Drugs; 1992 Nov; 10(4):313-6. PubMed ID: 1487406
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
[TBL] [Abstract][Full Text] [Related]
18. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Laurie SA; Pfister DG; Kris MG; Tong WP; Chronowski G; Pisters KM; Heelan RT; Sirotnak FM
Clin Cancer Res; 2001 Mar; 7(3):501-9. PubMed ID: 11297240
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancer.
Cheng EW; Currie VE; Yagoda A
Am J Clin Oncol; 1983 Aug; 6(4):469-71. PubMed ID: 6869317
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors.
Rigas JR; Kris MG; Miller VA; Pisters KM; Heelan RT; Grant SC; Fennelly DW; Chou TC; Sirotnak FM
Ann Oncol; 1999 May; 10(5):601-3. PubMed ID: 10416013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
